In patients with systemic inflammatory response syndrome (SIRS), tolerance of peripheral blood mononuclear cells to a second challenge with lipopolysaccharide (LPS) has been described. Thoracic duct lymph transports LPS and represents the extravascular, interstitial fluid compartment of the body. The aim of this study was to determine the capacity of lymph to influence LPS-induced cytokine production in vitro. Thoracic duct lymph was obtained from patients with SIRS and without SIRS (controls). The effect of lymph and simultaneously collected plasma on LPS-induced cytokine production by normal peripheral blood mononuclear cells was assessed. Both lymph and plasma of patients with SIRS reduced LPS-induced tumor necrosis factor-a and interleukin-6 production (P õ .01); lymph of controls also inhibited cytokine production (P õ .01), although to a lesser extent. This study suggests that LPS tolerance may occur both in the intra-and extravascular compartments.
Lipopolysaccharide (LPS) tolerance is characterized by [8] . Increased levels of these LPS-modulating substances have been detected in plasma of patients with sepsis [9, 10]. down-regulation of the production of proinflammatory cytokines (tumor necrosis factor-a (TNF-a), interleukin [IL]-6) but
In this study, we sought to determine the capacity of lymph to influence LPS-induced cytokine production. We therefore with an enhanced synthesis of IL-1 receptor antagonist upon ex vivo restimulation of mononuclear cells with LPS [1, 2] . obtained thoracic duct lymph of patients with and without SIRS and assessed the effect of lymph and simultaneously collected This phenomenon has been found in patients with systemic inflammatory response syndrome (SIRS) and in healthy hu-plasma on cytokine production by normal peripheral blood mononuclear cells (PBMC) stimulated with LPS. Further, to mans injected with low-dose LPS [1, 2] . Although the precise mechanisms of LPS tolerance are unclear, it is caused at least obtain insight into the potential role of LBP, BPI, and IL-10, the concentrations of these substances were measured in lymph in part by soluble mediators in the circulation, since serum of septic patients and endotoxemic volunteers partly reproduced and plasma. the LPS-tolerant state in normal whole blood [2, 3] as bactericidal/permeability-increasing protein (BPI) [7] . In ad-Lymph was obtained directly after the catheter was inserted into dition, the antiinflammatory cytokine IL-10 is considered to the thoracic duct.
antagonize LPS-induced toxicity by deactivation of monocytes
In patients without SIRS, undergoing a transthoracic resection including the thoracic duct for carcinoma of the esophagus or gastroesophageal junction, the thoracic duct was cannulated with a 14-gauge single-lumen catheter (Ohmeda) approximately at the tant and plasma were aliquoted and stored at 080ЊC until further Effect of lymph. Lymph of patients with SIRS and controls processing.
(patients without SIRS) reduced TNF-a and IL-6 production PBMC isolation. Blood was obtained aseptically from 12 after stimulation with 1 ng/mL LPS (P õ .01 vs. LPS only; healthy male volunteers (age 33 { 2 years). Blood from each figure 1). At 10 ng/mL LPS, IL-6 production was significantly volunteer was transferred immediately into pyrogen-free tubes that inhibited only by SIRS lymph (P õ .01 vs. LPS only; figure contained pyrogen-free heparin. Blood was diluted 1:1 in Hanks' 1). SIRS lymph was more potent than lymph of controls in Buffered Salt Solution (HBSS; BioWhittaker, Verviers, Belgium) inhibiting TNF-a production elicited by 1 ng/mL LPS (P õ and subsequently PBMC of each volunteer were isolated by cen-.05) and in inhibiting both TNF-a and IL-6 production elicited trifugation over a density gradient (Lymphopaque Ficoll Paque; by 10 ng/mL LPS (P õ .05; figure 1 ).
Pharmacia, Woerden, The Netherlands) at room temperature for Comparison of lymph and plasma. Plasma obtained from 15 min at 600 g. Cells in the interphase were collected, washed twice and thereafter brought to a concentration of 1 1 10 6 PBMC/ healthy volunteers inhibited TNF-a and IL-6 production (P õ mL in HBSS containing 10% sterile nonacute human serum (Cen-.05 vs. LPS only, except for IL-6 release at 10 ng/mL LPS;
tral Laboratory of The Netherlands Red Cross Blood Transfusion figure 1), confirming a previous report [2] . The extent of inhibi-Service (CLB), Amsterdam) [12] . tion by healthy plasma was less (P õ .05) compared with the different between the 2 groups. LBP levels were higher in SIRS After centrifugation at 2000 g for 30 min at 4ЊC, supernatants plasma than in SIRS lymph (P õ .03). IL-10 concentrations were aliquoted and stored at 080ЊC until assays were performed.
were higher in SIRS lymph than in SIRS plasma (P õ .02).
An identical protocol was used to determine LPS-neutralizing capacities of 10% plasma of patients with SIRS, 10% plasma of patients without SIRS, and 10% plasma of 10 healthy volunteers septic patients and endotoxemic volunteers partially reproduced the LPS-tolerant state in normal whole blood [2, 3] . It has not Results previously been studied whether, in the interstitial fluid, an LPS-tolerant state is present, presumably reflecting processes Incubation without LPS. Incubation of normal PBMC without LPS only resulted in detectable levels of TNF-a and at tissue-level. Therefore, we aimed to investigate the capacity of thoracic duct lymph from patients with SIRS to influence IL-6 in the presence of lymph or plasma of patients with SIRS. In these samples, TNF-a levels were 39 { 15 pg/mL (incuba-LPS-induced cytokine production, since thoracic duct lymph has been shown to represent the interstitial fluid compartment tion with lymph) and 10 { 7 pg/mL (incubation with plasma); IL-6 concentrations were 1774 { 88 and 502 { 43 pg/mL, [5] . Patients without SIRS, undergoing a transthoracic resection respectively. Therefore, the ex vivo production of TNF-a and IL-6 was calculated as the difference between cytokine concen-of the esophagus for a carcinoma of the esophagus, were used as controls. It is possible that these patients have characteristics trations found after incubation with LPS and those found after incubation without LPS.
Discussion
that differ from healthy individuals. However, we assume that / 9d50$$se05 08-04-98 08:40:22 jinfal UC: J Infect these patients closely approximate the condition of healthy volunteers, the ideal control group. TNF-a and IL-6 production by normal PBMC. This was also and interleukin-10 (IL-10) in lymph and plasma of patients with and found for plasma of patients with SIRS, as described previously without SIRS. [3] . Lymph and plasma of patients without SIRS, undergoing major surgery, also inhibited the LPS-induced proinflammatory 
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